Reverse Medical has announced receiving CE mark approval for the Barrel vascular reconstruction device and its first use in a European clinical case. The Barrel vascular reconstruction device is intended for use with occlusive devices in the treatment of intracranial aneurysms.
“Our first experience with the Barrel vascular reconstruction device in a wide-neck bifurcation intracranial aneurysm was impressive. The device tracked easily through tortuous anatomy, had excellent angiographic visibility, was easily and completely re-sheathable, and deployed very nicely. The device required no radial orientation manoeuvres for accurate placement, providing a single device alternative to surgery, or to technically challenging ’X-Y’ stenting for these complex bifurcation aneurysms,” stated Michel Piotin, director, Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France.
Reverse Medical president and CEO Jeffrey Valko commented, “The Barrel vascular reconstruction device represents our ongoing commitment as a neuroendovascular technology innovation company. We plan to expand our clinical experience with the Barrel technology, and begin commercialisation in Europe through a network of expert distributors by mid-2014. The design is simple and elegant, essentially reducing the neck size of wide-neck bifurcation aneurysms, enabling traditional coil embolization, a craft already mastered by the neurointerventionalist.”
